| Patent | Date |
|---|
Modulators of STING (Stimulator of Interferon Genes)
App 20220306641 - GAJIWALA; Ketan Satish ; et al. | 2022-09-29 |
Nitrile-containing antiviral compounds
Grant 11,452,711 - Owen , et al. September 27, 2 | 2022-09-27 |
Anti-avbeta8 Antibodies And Compositions And Uses Thereof
App 20220289850 - Niessen; Kyle Steven ; et al. | 2022-09-15 |
Anti-proliferative agents for treating PAH
Grant 11,439,646 - Evans September 13, 2 | 2022-09-13 |
Antibodies specific for CD3 and uses thereof
Grant 11,434,292 - Apgar , et al. September 6, 2 | 2022-09-06 |
Toll-like Receptor Agonists
App 20220274986 - Ahmad; Omar ; et al. | 2022-09-01 |
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
Grant 11,426,456 - Gu , et al. August 30, 2 | 2022-08-30 |
Antibodies specific for FLT3 and their uses
Grant 11,421,040 - Dettling , et al. August 23, 2 | 2022-08-23 |
Nitrile-Containing Antiviral Compounds
App 20220257563 - Owen; Dafydd Rhys ; et al. | 2022-08-18 |
Immunogenic compositions for use in pneumococcal vaccines
Grant 11,413,344 - Cooper , et al. August 16, 2 | 2022-08-16 |
Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth
App 20220251066 - Luzzio; Michael Joseph ; et al. | 2022-08-11 |
Cycloalkyl and Heterocycloalkyl Benzisoxazole Sulfonamide Derivatives
App 20220251075 - Brodsky; Oleg ; et al. | 2022-08-11 |
Combination Therapies Using Cdk Inhibitors
App 20220241412 - Dann; Stephen George ; et al. | 2022-08-04 |
Pd-1 Axis Binding Antagonist To Treat Cancer With Genetic Mutations In Specific Genes
App 20220241263 - Alimzhanov; Marat ; et al. | 2022-08-04 |
Combination Therapies Using Cdk Inhibitors
App 20220235141 - Dann; Stephen George ; et al. | 2022-07-28 |
CDK2/4/6 inhibitors
Grant 11,396,512 - Behenna , et al. July 26, 2 | 2022-07-26 |
Chimeric antigen receptors targeting CD70
Grant 11,396,551 - Srivatsa Srinivasan , et al. July 26, 2 | 2022-07-26 |
Protease-activating Cd45-gate Car
App 20220227832 - LANG; Shanshan ; et al. | 2022-07-21 |
Chimeric Antigen Receptors Targeting Epidermal Growth Factor Receptor Variant Iii
App 20220227874 - Wong; Oi Kwan ; et al. | 2022-07-21 |
6,7,8,9-tetrahydro-5H-pyrido[2,3-d]azepine dopamine D3 ligands
Grant 11,390,623 - Chappie , et al. July 19, 2 | 2022-07-19 |
Dosing Regimen Of Avelumab For The Treatment Of Cancer
App 20220220205 - Andrews; Glen Ian ; et al. | 2022-07-14 |
Metabolites Of Glp1r Agonists
App 20220213072 - Bessire; Andrew John ; et al. | 2022-07-07 |
Antibodies specific for CD70 and their uses
Grant 11,377,500 - Panowski , et al. July 5, 2 | 2022-07-05 |
Real-time Tracking And Management Of Standard Workflows
App 20220207454 - CAREY; Michael P. ; et al. | 2022-06-30 |
E. Coli Fimh Mutants And Uses Thereof
App 20220202923 - Che; Ye ; et al. | 2022-06-30 |
Metabolites Of Glp1r Agonists
App 20220193063 - Bessire; Andrew John ; et al. | 2022-06-23 |
Cysteine engineered antibody drug conjugates
Grant 11,364,303 - Katragadda , et al. June 21, 2 | 2022-06-21 |
Anti-ROBO2 antibodies, compositions, methods and uses thereof
Grant 11,365,253 - Berasi , et al. June 21, 2 | 2022-06-21 |
Bifunctional cytotoxic agents containing the CTI pharmacophore
Grant 11,365,263 - Maderna , et al. June 21, 2 | 2022-06-21 |
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens, Kits Comprising The Same And Uses Thereof
App 20220184199 - Anderson; Annaliesa Sybil ; et al. | 2022-06-16 |
(AZA)Benzothiazolyl Substituted Pyrazole Compounds
App 20220184041 - Cabral; Shawn ; et al. | 2022-06-16 |
Anti-AVB8 antibodies and compositions and uses thereof
Grant 11,359,024 - Niessen , et al. June 14, 2 | 2022-06-14 |
Stable Liquid Antibody Formulation
App 20220175663 - Badkar; Advait Vijay ; et al. | 2022-06-09 |
Nitrile-containing antiviral compounds
Grant 11,351,149 - Owen , et al. June 7, 2 | 2022-06-07 |
Escherichia Coli Compositions And Methods Thereof
App 20220168410 - Donald; Robert G.K. ; et al. | 2022-06-02 |
Time To Resolution Of Axitinib-related Adverse Events
App 20220168293 - Thomaidou; Despoina | 2022-06-02 |
Compositions And Methods For Eliciting An Immune Response Against Clostridium Difficile
App 20220160859 - Jansen; Kathrin Ute ; et al. | 2022-05-26 |
Toll-like receptor agonists
Grant 11,339,159 - Ahmad , et al. May 24, 2 | 2022-05-24 |
Escherichia Coli Compositions And Methods Thereof
App 20220152181 - Anderson; Annaliesa Sybil ; et al. | 2022-05-19 |
Crystalline Pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone Compound And Use Thereof
App 20220144846 - YANG; Xiaojing ; et al. | 2022-05-12 |
Nitrile-Containing Antiviral Compounds
App 20220142976 - Owen; Dafydd Rhys ; et al. | 2022-05-12 |
Tofacitinib Oral Sustained Release Dosage Forms
App 20220142927 - Herbig; Scott Max ; et al. | 2022-05-12 |
Site-specific integration
Grant 11,326,185 - Rance , et al. May 10, 2 | 2022-05-10 |
Crystalline 2-amino-2-(hydroxymethyl)propane-1,3-diol salt of 4-(4-(1-isopropyl-7-OXO-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]- -1'-carbonyl)-6-methoxypryridin-2-YL)benzoic acid
Grant 11,325,909 - Fernando , et al. May 10, 2 | 2022-05-10 |
Method of treatment of Chronic Low Back Pain
App 20220135663 - WEST; Christine Ruth ; et al. | 2022-05-05 |
Methods for purifying bacterial polysaccharides
App 20220136020 - Chu; Ling ; et al. | 2022-05-05 |
Combination Of A Cdk Inhibitor And A Pim Inhibitor
App 20220125777 - Zhu; Zhou ; et al. | 2022-04-28 |
Manufacturing Process And Intermediates For A Pyrrolo[2,3-d]pyrimidine Compound And Use Thereof
App 20220127274 - Arora; Kapildev Kashmirilal ; et al. | 2022-04-28 |
Crystalline Form Of A Cdk Inhibitor
App 20220127262 - Behenna; Douglas Carl ; et al. | 2022-04-28 |
Chimeric antigen receptors targeting B-cell maturation antigen
Grant 11,312,782 - Kuo , et al. April 26, 2 | 2022-04-26 |
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors
Grant 11,312,713 - Brodney , et al. April 26, 2 | 2022-04-26 |
Neisseria Meningitidis Compositions And Methods Thereof
App 20220118072 - Anderson; Annaliesa Sybil ; et al. | 2022-04-21 |
Antibodies to MAdCAM
App 20220119521 - Anderson; Karin | 2022-04-21 |
Cdcp1-targeted Therapies
App 20220119545 - CANTLEY; Lewis C. ; et al. | 2022-04-21 |
CD1a ANTIBODIES AND USES THEREOF
App 20220112291 - WINAU; Florian ; et al. | 2022-04-14 |
Crystalline form of lorlatinib free base hydrate
Grant 11,299,500 - Bowles , et al. April 12, 2 | 2022-04-12 |
Glycoconjugation Processes And Compositions
App 20220096619 - Gu; Jianxin ; et al. | 2022-03-31 |
Method of Treating Signs and Symptoms of Osteoarthritis
App 20220089710 - WEST; Christine Ruth ; et al. | 2022-03-24 |
Human Cytomegalovirus Gb Polypeptide
App 20220088184 - Liu; Yuhang ; et al. | 2022-03-24 |
Cyclin Dependent Kinase Inhibitors
App 20220089580 - Chen; Ping ; et al. | 2022-03-24 |
Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h,6h) Carbaldehyde Derivatives
App 20220089613 - LI; Hui ; et al. | 2022-03-24 |
Antibodies specific for epidermal growth factor receptor variant III and their uses
Grant 11,279,764 - Wong , et al. March 22, 2 | 2022-03-22 |
Dosing regimen of avelumab for the treatment of cancer
Grant 11,274,154 - Andrews , et al. March 15, 2 | 2022-03-15 |
Cells with reduced inhibitor production and methods of use thereof
App 20220073942 - DEUTSCHMAN; Emily Ann ; et al. | 2022-03-10 |
Pharmaceutical Compositions and Methods Comprising A Combination of a Benzoxazole Transthyretin Stabilizer and an Additional Therapeutic Agent
App 20220071965 - Bulawa; Christine Ellen ; et al. | 2022-03-10 |
Chimeric antigen receptors targeting epidermal growth factor receptor variant III
Grant 11,267,892 - Wong , et al. March 8, 2 | 2022-03-08 |
Nitrile-Containing Antiviral Compounds
App 20220062232 - Owen; Dafydd Rhys ; et al. | 2022-03-03 |
Escherichia coli compositions and methods thereof
Grant 11,260,119 - Donald , et al. March 1, 2 | 2022-03-01 |
Synthesis Of Pyrido[2,3-d]pyrimidin-7(8h)-ones
App 20220056025 - Brown; Adam Ross ; et al. | 2022-02-24 |
Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives
Grant 11,254,668 - Gerstenberger , et al. February 22, 2 | 2022-02-22 |
Combinations for treatment of NASH/NAFLD and related diseases
Grant 11,254,660 - Esler , et al. February 22, 2 | 2022-02-22 |
Manufacturing process and intermediates for a pyrrolo[2,3-d]pyrimidine compound and use thereof
Grant 11,254,684 - Arora , et al. February 22, 2 | 2022-02-22 |
Tofacitinib oral sustained release dosage forms
Grant 11,253,523 - Herbig , et al. February 22, 2 | 2022-02-22 |
Ssi Cells With Predictable And Stable Transgene Expression And Methods Of Formation
App 20220049275 - O'CALLAGHAN; PETER M. ; et al. | 2022-02-17 |
Combination Of A Pd-1 Antagonist, An Atr Inhibitor And A Platinating Agent For The Treatment Of Cancer
App 20220048997 - Alimzhanov; Marat ; et al. | 2022-02-17 |
Recombinant Vaccinia Virus
App 20220033784 - Binder; Joseph John ; et al. | 2022-02-03 |
Combinations For Treatment Of NASH/NAFLD And Related Diseases
App 20220023299 - Esler; William Paul ; et al. | 2022-01-27 |
Btla Fusion Protein Agonists And Uses Thereof
App 20220025017 - WARE; Carl F. ; et al. | 2022-01-27 |
Crystalline Forms Of 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyan- Ophenyl)urea Maleate
App 20220024894 - Hansen; Eric Christian ; et al. | 2022-01-27 |
Crystalline Forms Of 1-((2r,4r)-2-(1h-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyan- Ophenyl)urea Maleate
App 20220024893 - Hansen; Eric Christian ; et al. | 2022-01-27 |
Compounds and Methods for the Treatment of COVID-19
App 20220017548 - Kania; Robert Steven ; et al. | 2022-01-20 |
Therapeutic Antibodies And Their Uses
App 20220017622 - APGAR; JAMES REASONER ; et al. | 2022-01-20 |
Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof
App 20220016229 - Prasad; Avvari Krishna ; et al. | 2022-01-20 |
Cyclin dependent kinase inhibitors
Grant 11,220,494 - Chen , et al. January 11, 2 | 2022-01-11 |
Substituted n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as protein kinase C inhibitors
Grant 11,220,518 - Li , et al. January 11, 2 | 2022-01-11 |
Binding Molecules To The Human Ox40 Receptor
App 20220002428 - MIN; Jing ; et al. | 2022-01-06 |
Aminopyrimidinyl Derivatives
App 20220002301 - GERSTENBERGER; Brian Stephen ; et al. | 2022-01-06 |
Immunogenic Compositions And Uses Thereof
App 20220000999 - Anderson; Annaliesa Sybil ; et al. | 2022-01-06 |
Antibodies To Coagulation Factor Xia And Uses Thereof
App 20210403600 - MIKITA; Thomas ; et al. | 2021-12-30 |
Compositions and methods relating to a mutant Clostridium difficile toxin
Grant 11,208,633 - Lotvin , et al. December 28, 2 | 2021-12-28 |
Immunogenic Compositions for Use in Pneumococcal Vaccines
App 20210393764 - Cooper; David ; et al. | 2021-12-23 |
Dosage Regimen for TFPI Antagonists
App 20210395391 - Zhu; Tong ; et al. | 2021-12-23 |
Anti-proliferative agents for treating PAH
Grant 11,203,594 - Bhattacharya , et al. December 21, 2 | 2021-12-21 |
Combination for Treating Cancer
App 20210386826 - Boshoff; Christoffel Hendrik ; et al. | 2021-12-16 |
Crystalline Forms Of Lorlatinib Maleate
App 20210388000 - Pencheva; Klimentina Dimitrova | 2021-12-16 |
Pyrrolo[2,3-d]pyrimidine Tosylate Salt, Crystalline Form Thereof And Manufacturing Process And Intermediates Thereto
App 20210387989 - SAMAS; Brian Matthew ; et al. | 2021-12-16 |
Polymorph Form Of A Monophosphate Hydrate Salt Of A Known Tetrahydroisoquinoline Derivative
App 20210387992 - Samas; Brian ; et al. | 2021-12-16 |
Aminopyrimidinyl compounds
Grant 11,197,867 - Fensome , et al. December 14, 2 | 2021-12-14 |
Dihydro-pyrrolo-pyridine derivatives
Grant 11,198,692 - Beck , et al. December 14, 2 | 2021-12-14 |
Glycoconjugation Process
App 20210371453 - Han; Mingming ; et al. | 2021-12-02 |
Aminopyrimidinyl Compounds
App 20210377495 - FENSOME; Andrew ; et al. | 2021-12-02 |
Novel Imidazo[4,5-c]quinoline Derivatives As Lrrk2 Inhibitors
App 20210355117 - BRODNEY; Michael Aaron ; et al. | 2021-11-18 |
Compounds And Uses Thereof To Treat Tumors In A Subject
App 20210353614 - Zimmermann; Astrid ; et al. | 2021-11-18 |
Combinations for Treating Cancer
App 20210355223 - Boshoff; Christoffel Hendrik ; et al. | 2021-11-18 |
Vectors for expression of prostate-associated antigens
Grant 11,173,196 - Binder November 16, 2 | 2021-11-16 |
Combinations Of Tgf-beta Inhibitors And Cdk Inhibitors For Cancer Treatments
App 20210346384 - PERNASETTI; Flavia Mercer | 2021-11-11 |
Crystalline forms of 1-((2R,4R)-2-(1H-benzo[d]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyan- ophenyl)urea maleate
Grant 11,168,066 - Seadeek November 9, 2 | 2021-11-09 |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
Grant 11,160,855 - Emini , et al. November 2, 2 | 2021-11-02 |
Cyclic substituted imidazo[4,5-c]quinoline derivatives
Grant 11,161,844 - Chappie , et al. November 2, 2 | 2021-11-02 |
GLP-1 Receptor Agonists and Uses Thereof
App 20210332034 - Aspnes; Gary Erik ; et al. | 2021-10-28 |
Therapeutic antibodies and their uses
Grant 11,155,630 - Kuo , et al. October 26, 2 | 2021-10-26 |
IL-15 Variants and Uses Thereof
App 20210324028 - Yeung; Yik Andy ; et al. | 2021-10-21 |
Dosage Regimen For MAdCAM Antagonists
App 20210324070 - CATALDI; Fabio ; et al. | 2021-10-21 |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
Grant 11,147,852 - Marquette , et al. October 19, 2 | 2021-10-19 |
Immunogenic compositions and uses thereof
Grant 11,147,865 - Anderson , et al. October 19, 2 | 2021-10-19 |
Solid Dosage Forms Of Palbociclib
App 20210315900 - Ibrahim; Fady Makram Louiz ; et al. | 2021-10-14 |
Azalactam compounds as HPK1 inhibitors
Grant 11,142,525 - Gallego , et al. October 12, 2 | 2021-10-12 |
Heteroaryl Sulfone-based Conjugation Handles, Methods For Their Preparation, And Their Use In Synthesizing Antibody Drug Conjugates
App 20210308276 - DUSHIN; Russell George ; et al. | 2021-10-07 |
Heterocyclic Spiro Compounds As MAGL Inhibitors
App 20210309669 - Brodney; Michael Aaron ; et al. | 2021-10-07 |
Soluble Fibroblast Growth Factor Receptor 3 (sfgfr3) Polypeptides And Uses Thereof
App 20210309718 - Gouze; Elvire ; et al. | 2021-10-07 |
Diacylglycerol Acyl Transferase 2 Inhibitors
App 20210309646 - Boehm; Markus ; et al. | 2021-10-07 |
Substituted 3-azabicyclo[3.1.0]hexanes As Ketohexokinase Inhibitors
App 20210309644 - Dowling; Matthew ; et al. | 2021-10-07 |
5,7-dihydro-pyrrolo-pyridine Derivatives
App 20210309659 - Zhang; Lei ; et al. | 2021-10-07 |
Immunogenic compositions for use in pneumococcal vaccines
Grant 11,135,279 - Cooper , et al. October 5, 2 | 2021-10-05 |
Heteroaromatic Compounds And Their Use As Dopamine D1 Ligands
App 20210300899 - Brodney; Michael Aaron ; et al. | 2021-09-30 |
Glycoconjugation process
Grant 11,117,928 - Han , et al. September 14, 2 | 2021-09-14 |
Glycoconjugation processes and compositions
Grant 11,110,160 - Gu , et al. September 7, 2 | 2021-09-07 |
Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides
Grant 11,111,242 - Thorarensen , et al. September 7, 2 | 2021-09-07 |
Prostate-associated antigens and vaccine-based immunotherapy regimens
Grant 11,110,158 - Binder , et al. September 7, 2 | 2021-09-07 |
Pharmaceutical Aqueous Formulation Comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorph- Olin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
App 20210267988 - Hussey; James Joseph ; et al. | 2021-09-02 |
Escherichia Coli Compositions And Methods Thereof
App 20210268095 - Donald; Robert G.K. ; et al. | 2021-09-02 |
Solid State Forms Of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2- -methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide And Uses Thereof
App 20210269407 - GREER; Elaine ; et al. | 2021-09-02 |
Cdk2 Inhibitors
App 20210269425 - Behenna; Douglas Carl ; et al. | 2021-09-02 |
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens, Kits Comprising The Same And Uses Thereof
App 20210260177 - Watson; Wendy Jo ; et al. | 2021-08-26 |
Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making And Using Same
App 20210259982 - Horhota; Allen Thomas ; et al. | 2021-08-26 |
Cdk2 Inhibitors
App 20210261530 - Behenna; Douglas Carl ; et al. | 2021-08-26 |
Methods Of Treating Cancer Using Combination Therapy
App 20210252143 - Russell; Stephen J. ; et al. | 2021-08-19 |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
Grant 11,090,375 - Emini , et al. August 17, 2 | 2021-08-17 |
Anti-e-selectin Antibodies, Compositions And Methods Of Use
App 20210246213 - Apgar; James Reasoner ; et al. | 2021-08-12 |
Crystalline forms of lorlatinib maleate
Grant 11,078,215 - Pencheva August 3, 2 | 2021-08-03 |
Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes)
App 20210230196 - Wythes; Martin James ; et al. | 2021-07-29 |
Solid dosage forms of palbociclib
Grant 11,065,250 - Ibrahim , et al. July 20, 2 | 2021-07-20 |
Antibodies to coagulation factor XIa and uses thereof
Grant 11,066,481 - Mikita , et al. July 20, 2 | 2021-07-20 |
Diacylglycerol acyl transferase 2 inhibitor
Grant 11,065,249 - Edmonds , et al. July 20, 2 | 2021-07-20 |
Aqueous Formulation Comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorph- Olin-4-yl-1,3,5-triazin-2-yl)phenyl]urea
App 20210212944 - Hussey; James Joseph ; et al. | 2021-07-15 |
Recombinant Robo2 Proteins, Compositions, Methods And Uses Thereof
App 20210214414 - Berasi; Stephen ; et al. | 2021-07-15 |
BCKDK inhibitors
Grant 11,059,833 - Bhattacharya , et al. July 13, 2 | 2021-07-13 |
Aqueous pharmaceutical formulation comprising anti-PD-L1 antibody Avelumab
Grant 11,058,769 - Rinaldi , et al. July 13, 2 | 2021-07-13 |
IL-15 variants and uses thereof
Grant 11,059,876 - Yeung , et al. July 13, 2 | 2021-07-13 |
Cancer vaccines
Grant 11,058,753 - Binder , et al. July 13, 2 | 2021-07-13 |
Oral Solution Formulation
App 20210205309 - JAIN; Ashwinkumar ; et al. | 2021-07-08 |
Stability-modulating Linkers For Use With Antibody Drug Conjugates
App 20210205463 - DUSHIN; Russell George ; et al. | 2021-07-08 |
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides Useful As Ccr6 Inhibitors
App 20210206757 - Gerstenberger; Brian Stephen ; et al. | 2021-07-08 |
Oligonucleotide Compositions And Methods Of Use Thereof
App 20210198305 - Vargeese; Chandra ; et al. | 2021-07-01 |
Methods of Treating Metabolic Disease
App 20210196823 - Drakesmith; Alexander Hal ; et al. | 2021-07-01 |
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
App 20210196810 - Emini; Emilio Anthony ; et al. | 2021-07-01 |
Therapeutic Antibodies And Their Uses
App 20210188991 - KUO; Tracy Chia-Chien ; et al. | 2021-06-24 |
Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making and Using Same
App 20210188979 - Zale; Stephen E. | 2021-06-24 |
Anti-proliferative Agents For Treating Pah
App 20210186974 - Evans; Steven Martin | 2021-06-24 |
Chemical Compounds
App 20210188829 - Bagley; Scott William ; et al. | 2021-06-24 |
Antibodies Specific for CD47, PD-L1, and Uses Thereof
App 20210179716 - CHAPARRO RIGGERS; Javier Fernando ; et al. | 2021-06-17 |
Media And Fermentation Methods For Producing Polysaccharides In Bacterial Cell Culture
App 20210180008 - Desai; Sunil Gururao ; et al. | 2021-06-17 |
Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods Of Making And Using The Same
App 20210177857 - Bagrodia; Shubha ; et al. | 2021-06-17 |
Diacylglycerol acyl transferase 2 inhibitors
Grant 11,034,678 - Boehm , et al. June 15, 2 | 2021-06-15 |
Interferon Beta Antibodies And Uses Thereof
App 20210163588 - Gulla; Stefano V. ; et al. | 2021-06-03 |
GLP-1 Receptor Agonists and Uses Thereof
App 20210163455 - Aspnes; Gary Erik ; et al. | 2021-06-03 |
Crystalline form of lorlatinib free base
Grant 11,020,376 - Pencheva , et al. June 1, 2 | 2021-06-01 |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
Grant 11,020,469 - Watson , et al. June 1, 2 | 2021-06-01 |
Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof
Grant 11,021,528 - Gouze , et al. June 1, 2 | 2021-06-01 |
CDK2 inhibitors
Grant 11,014,911 - Behenna , et al. May 25, 2 | 2021-05-25 |
Chemical compounds
Grant 11,014,908 - Gopalsamy , et al. May 25, 2 | 2021-05-25 |
Heteroaromatic compounds and their use as dopamine D1 ligands
Grant 11,014,909 - Brodney , et al. May 25, 2 | 2021-05-25 |
Group B Streptococcus Polysaccharide-protein Conjugates, Methods For Producing Conjugates, Immunogenic Compositions Comprising Conjugates, And Uses Thereof
App 20210145957 - Anderson; Annaliesa Sybil ; et al. | 2021-05-20 |
Apixaban Formulations
App 20210145817 - BADAWY; Sherif Ibrahim Farag ; et al. | 2021-05-20 |
Stable Aqueous Antibody Formulation
App 20210128729 - INGRAM; REBECCA LEE ; et al. | 2021-05-06 |
Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates Thereof
App 20210121555 - Han; Mingming ; et al. | 2021-04-29 |
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
Grant 10,988,463 - Dowling , et al. April 27, 2 | 2021-04-27 |
Engineered Polypeptide Conjugates And Methods For Making Thereof Using Transglutaminase
App 20210115159 - STROP; Pavel ; et al. | 2021-04-22 |
Methods Of Glycoengineering Proteoglycans With Distinct Glycan Structures
App 20210115413 - Chang; Michelle ; et al. | 2021-04-22 |
Aminopyrimidinyl compounds
Grant 10,980,815 - Fensome , et al. April 20, 2 | 2021-04-20 |
Compositions and methods relating to a mutant Clostridium difficile toxin
Grant 10,982,198 - Lotvin , et al. April 20, 2 | 2021-04-20 |
Compositions Comprising Heterogeneous Populations Of Recombinant Human Clotting Factor Xa Proteins
App 20210106658 - JOHNSON; KEITH A. ; et al. | 2021-04-15 |
Dll3 Targeting Chimeric Antigen Receptors And Binding Agents
App 20210107979 - ZHANG; Yi ; et al. | 2021-04-15 |
N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as CCR6 inhibitors
Grant 10,975,065 - Gerstenberger , et al. April 13, 2 | 2021-04-13 |
Tissue Factor Pathway Inhibitor Antibodies And Uses Thereof
App 20210101998 - Pittman; Debra ; et al. | 2021-04-08 |
Diacylglycerol Acyl Transferase 2 Inhibitor
App 20210100798 - Edmonds; David James ; et al. | 2021-04-08 |
Aqueous Pharmaceutical Formulation Comprising Anti-pd-l1 Antibody Avelumab
App 20210100903 - RINALDI; Gianluca ; et al. | 2021-04-08 |
Diacylglycerol Acyl Transferase 2 Inhibitor
App 20210100796 - Edmonds; David James ; et al. | 2021-04-08 |
Anti-cxcr5 Antibodies And Compositions And Uses Thereof
App 20210101970 - Groth; Rachel ; et al. | 2021-04-08 |
Neisseria Meningitidis Compositions And Methods Thereof
App 20210101943 - Anderson; Annaliesa Sybil ; et al. | 2021-04-08 |
Stability-modulating linkers for use with antibody drug conjugates
Grant 10,967,068 - Dushin , et al. April 6, 2 | 2021-04-06 |
Pyrrolo[2,3-d]pyrimidine derivatives
Grant 10,966,980 - Vazquez , et al. April 6, 2 | 2021-04-06 |
Cyclopentane-based modulators of STING (stimulator of interferon genes)
Grant 10,968,242 - Wythes , et al. April 6, 2 | 2021-04-06 |
BTLA fusion protein agonists and uses thereof
Grant 10,961,297 - Ware , et al. March 30, 2 | 2021-03-30 |
Modulators of STING (Stimulator of Interferon Genes)
App 20210087180 - PATMAN; Ryan ; et al. | 2021-03-25 |
Bckdk Inhibitors
App 20210087204 - Bhattacharya; Samit Kumar ; et al. | 2021-03-25 |
Neisseria Meningitidis Compositions And Methods Thereof
App 20210085773A1 - | 2021-03-25 |
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
Grant 10,952,972 - Horhota , et al. March 23, 2 | 2021-03-23 |
Methods and Combination Therapy to Treat Cancer
App 20210077463A1 - | 2021-03-18 |
Combinations comprising a pyrrolidine-2,5-dione IDO1 inhibitor and an anti-body
Grant 10,945,994 - Kraus , et al. March 16, 2 | 2021-03-16 |
PDE4 inhibitor (R)-4-(5-(4-methoxy-3-propoxyphenyl)pyridin-3-yl)-1,2-oxaborolan-2-ol
Grant 10,946,031 - Strohbach , et al. March 16, 2 | 2021-03-16 |
Group B Streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
Grant 10,946,086 - Anderson , et al. March 16, 2 | 2021-03-16 |
Media and fermentation methods for producing polysaccharides in bacterial cell culture
Grant 10,947,494 - Desai , et al. March 16, 2 | 2021-03-16 |
Pd-l1 Antagonist Combination Treatments
App 20210069326A1 - | 2021-03-11 |
Boron Containing PDE4 Inhibitors
App 20210069219A1 - | 2021-03-11 |
Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2- -methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
Grant 10,941,118 - Greer , et al. March 9, 2 | 2021-03-09 |
Engineered polypeptide conjugates and methods for making thereof using transglutaminase
Grant 10,941,216 - Strop , et al. March 9, 2 | 2021-03-09 |
Anti-il-2 Antibodies And Compositions And Uses Thereof
App 20210061902A1 - | 2021-03-04 |
Bifunctional Cytotoxic Agents Containing The Cti Pharmacophore
App 20210061923A1 - | 2021-03-04 |
GLP-1 receptor agonists and uses thereof
Grant 10,934,279 - Aspnes , et al. March 2, 2 | 2021-03-02 |
Therapeutic Antibodies And Their Uses
App 20210054087A1 - | 2021-02-25 |
Anti-CXCR4 antibodies and antibody-drug conjugates
Grant 10,927,178 - Liu , et al. February 23, 2 | 2021-02-23 |
Glp-1 Receptor Agonists And Uses Thereof
App 20210047298A1 - | 2021-02-18 |
N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS
App 20210047325A1 - | 2021-02-18 |
Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
Grant 10,918,708 - Gu , et al. February 16, 2 | 2021-02-16 |
Humanized Antibodies
App 20210040182A1 - | 2021-02-11 |
Solid State Forms Of (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl)pentanamide And Uses Thereof
App 20210040045A1 - | 2021-02-11 |
Lfa3 Variants And Compositions And Uses Thereof
App 20210032308A1 - | 2021-02-04 |
Recombinant ROBO2 proteins, compositions, methods and uses thereof
Grant 10,906,955 - Berasi , et al. February 2, 2 | 2021-02-02 |
Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme
Grant 10,906,888 - Casimiro-Garcia , et al. February 2, 2 | 2021-02-02 |
RSV F Protein Mutants
App 20210023200A1 - | 2021-01-28 |
Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates Thereof
App 20210023193A1 - | 2021-01-28 |
Piperazine Azaspiro Derivaves
App 20210024497A1 - | 2021-01-28 |
Methods Of Administering Chimeric Antigen Receptor Immunotherapy In Combination With 4-1bb Agonist
App 20210023134A1 - | 2021-01-28 |
Compositions And Methods Relating To A Mutant Clostridium Difficile Toxin
App 20210024903A1 - | 2021-01-28 |
Neisseria Meningitidis Composition And Methods Thereof
App 20210024589A1 - | 2021-01-28 |
Bckdk Inhibitors
App 20210024536A1 - | 2021-01-28 |
Combination of a PD-1 antagonist and a 4-1BB agonist for treating cancer
Grant 10,899,840 - Davis , et al. January 26, 2 | 2021-01-26 |
Neisseria meningitidis compositions and methods thereof
Grant 10,899,802 - Anderson , et al. January 26, 2 | 2021-01-26 |
Cells And Method Of Cell Culture
App 20210017553A1 - | 2021-01-21 |
Pyridinone And Pyrimidinone Phosphates And Boronates Useful As Antibacterial Agents
App 20210017206A1 - | 2021-01-21 |
Fluoro-Pyridinone Phosphates And Boronates Useful As Antibacterial Agents
App 20210017205A1 - | 2021-01-21 |
Antibody Purification
App 20210017254A1 - | 2021-01-21 |
Toll-like Receptor Agonists
App 20210017172A1 - | 2021-01-21 |
Stable aqueous anti-vascular endothelial growth factor (VEGF) antibody formulation
Grant 10,894,083 - Ingram , et al. January 19, 2 | 2021-01-19 |
Soluble Fgfr3 Decoys For Treating Skeletal Growth Disorders
App 20210009657A1 - | 2021-01-14 |
Manufacturing Process And Intermediates For A Pyrrolo[2,3-d]pyrimidine Compound And Use Thereof
App 20210009601A1 - | 2021-01-14 |
Neisseria meningitidis compositions and methods thereof
Grant 10,888,611 - Jansen , et al. January 12, 2 | 2021-01-12 |
Combination Of An Anti-pd-l1 Antibody And Ido1 Inhibitor For The Treatment Of Cancer
App 20210002371A1 - | 2021-01-07 |
Anti-pd-1 Antibody Compositions
App 20210002369A1 - | 2021-01-07 |
Compositions And Methods For Counteracting Factor Xa Inhibition
App 20210000930A1 - | 2021-01-07 |
Bruton's Tyrosine Kinase Inhibitors
App 20210002251A1 - | 2021-01-07 |
Tissue factor pathway inhibitor antibodies and uses thereof
Grant 10,875,929 - Pittman , et al. December 29, 2 | 2020-12-29 |
Anti-CXCR5 antibodies and compositions and uses thereof
Grant 10,875,915 - Groth , et al. December 29, 2 | 2020-12-29 |
Pyrazolo[1,5-a]pyrazin-4-yl Derivatives
App 20200399281A1 - | 2020-12-24 |
Benzisoxazole Sulfonamide Derivatives
App 20200399258A1 - | 2020-12-24 |
PD-L1 antagonist combination treatments
Grant 10,869,924 - Andrews , et al. December 22, 2 | 2020-12-22 |
Bifunctional cytotoxic agents containing the CTI pharmacophore
Grant 10,870,706 - Maderna , et al. December 22, 2 | 2020-12-22 |
CDK2/4/6 Inhibitors
App 20200392142A1 - | 2020-12-17 |
MUTEINS OF CLOTTING FACTOR Vlll
App 20200392205A1 - | 2020-12-17 |
Heterocyclic spiro compounds as MAGL inhibitors
Grant 10,858,373 - Brodney , et al. December 8, 2 | 2020-12-08 |
Site Specific Her2 Antibody Drug Conjugates
App 20200377615A1 - | 2020-12-03 |
Bicyclic-Fused Heteroaryl or Aryl Compounds
App 20200377511A1 - | 2020-12-03 |
Apixaban Formulations
App 20200375968A1 - | 2020-12-03 |
Substituted 3-azabicyclo[3.1.0]hexanes As Ketohexokinase Inhibitors
App 20200377482A1 - | 2020-12-03 |
Tissue-specific genome engineering using CRISPR-Cas9
Grant 10,851,367 - Liras , et al. December 1, 2 | 2020-12-01 |
Dosage regimen for MAdCAM antagonists
Grant 10,851,163 - Cataldi , et al. December 1, 2 | 2020-12-01 |
GLP-1 receptor agonists and uses thereof
Grant 10,851,081 - Aspnes , et al. December 1, 2 | 2020-12-01 |
Anti-proliferative agents for treating PAH
Grant 10,849,903 - Evans December 1, 2 | 2020-12-01 |
Reagents for fluorosulfating alcohols or amines
Grant 10,836,717 - Zhou , et al. November 17, 2 | 2020-11-17 |
Neisseria meningitidis composition and methods thereof
Grant 10,829,521 - Anderson , et al. November 10, 2 | 2020-11-10 |
Interferon beta antibodies and uses thereof
Grant 10,829,553 - Gulla , et al. November 10, 2 | 2020-11-10 |
| 